KOL Perspective: IL-6 Inhibitors in Rheumatoid Arthritis: Tocilizumab Likely to Initiate Effective Treatment
Prevalent among patients of rheumatoid arthritis, interleukin 6 or IL-6 is relevant to many inflammatory disease which simulates energy mobilization in muscle and fatty tissue, resulting into increased body temperature. It has inhibitory effects on TNF-alpha involved in various autoimmune and immune-mediated disorders such as rheumatoid arthritis. Therefore, anti-IL6 agents or IL-6 inhibitors are mostly sought after for rheumatoid arthritis patients who are unresponsive to TNF inhibitors. Growing prevalence of the disease has garnered significant development ventures from major pharmaceutical...
View full press release